TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
VLVbio AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,052
|
1,219
|
1,196 |
| Financial expenses |
11
|
9
|
8 |
| Earnings before taxes |
-138
|
-115
|
-61 |
| EBITDA |
-133
|
-90
|
-38 |
| Total assets |
1,284
|
1,189
|
1,096 |
| Current assets |
1,280
|
1,187
|
1,081 |
| Current liabilities |
1,280
|
1,185
|
1,092 |
| Equity capital |
4
|
5
|
4 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
7
|
7
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
0.3%
|
0.4%
|
0.4% |
| Turnover per employee |
150
|
174
|
239 |
| Profit as a percentage of turnover |
-13.1%
|
-9.4%
|
-5.1% |
| Return on assets (ROA) |
-9.9%
|
-8.9%
|
-4.8% |
| Current ratio |
100%
|
100.2%
|
99.0% |
| Return on equity (ROE) |
-3450.0%
|
-2300%
|
-1525.0% |
| Change turnover |
-125
|
20
|
192 |
| Change turnover % |
-11%
|
2%
|
19% |
| Chg. No. of employees |
0
|
2
|
-2 |
| Chg. No. of employees % |
0%
|
40%
|
-29% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.